Abstract
Abstract
Guideline & Submission
Important Dates
-
Deadline for Abstract SubmissionJanuary 24, 2024
-
Notification of Abstract AcceptanceFebruary 26, 2024
-
Late-breaking Abstract SubmissionFebruary 16 ~ March 4, 2024
-
Notification of Acceptance for Late-breaking AbstractMarch 18, 2024
Online Submission
Abstract Submission Guideline
- All abstracts must be submitted via the Online System only.
- The abstract submitter must choose one topic from the category.
- Submitting an abstract does not automatically register you for to KCR 2024. Please ensure that all abstract presenters also complete the registration process.
- Authors are able to modify their abstracts until the submission deadline on the website.
- When you submit your abstract online, your abstract will be automatically edited according to KCR 2024 submission formats.
- It is the authors' responsibility to review the submissions and correct them. Submitters are responsible for all typing errors in the abstract.
- The submission form is intended for the review of the abstract.
- A confirmation letter of abstract submission will be automatically sent to the submitter and corresponding author by e-mail upon the completion of the online submission.
Encore Presentation
- An encore presentation is one where you have already presented the submitted work before.
- Encore presentations are permitted as long as work has been presented after last KCR (17-20 May 2023) when you have presented the work at another academic conference.
- Encore presentations are permitted as long as work has not previously been published prior to submission.
- Publication in a print or online journal of the abstract in a scientific journal after the submission deadline is not in conflict with presenting it at KCR 2024.
- Abstracts published before the abstract review or posted in online journals cannot be submitted.
- When the abstract is found that it has been published or posted in an online journal before the abstract review, it will be excluded from the review.
- Encore submissions must disclose the name and date of the meeting at which they were presented if they are updated or enhanced (e.g. added number or method of analysis, etc.).
- Encore submissions must disclose the name and date of the meeting at which they were presented if they are updated or enhanced such as added number or method of analysis, etc. (e.g. "This abstract was presented previously in ACR 2023 conference, at Oct - 2023")
Embargo Policy
- Communication and/or dissemination of abstracts and information contained therein intended for presentations and/or lectures at the KCR 2024 is prohibited during the embargo period; i.e. starting from the date of acceptance notice until the start of each individual presentation. After the presentation, KCR will allow dissemination and submission to any other third party.
- KCR 2024’s permission is required prior to dissemination and/or submission to any other third party. In case of any violation of the above-stated policies, KCR 2024, the copyright holder, reserves the right to take appropriate action, including withdrawal of the concerned abstract.
Conflict of Interest Disclosure
- If there is the relevant financial activities outside the submitted work, the submitter, who entrust by all of the co-authors, must complete a disclosure form for potential conflict of interest when they submit their abstract. A conflict of interest may exist when an author (or author's institution or employer) has financial or personal relationships or affiliations that could influence (or bias) the author's decisions, work, or abstract. Please find the Conflict of Interest Disclosure Form below.
Conflict of Interest Disclosure Form
Guidelines for Submission
| Language | English Only |
|---|---|
| Presentation Type |
1) Original Article (Oral or Poster) 2) Case Report (Poster) |
| Title | Only the first letter of the title should start with a capital letter, except for proper nouns. |
| Format |
Original Research – Oral or Poster / Poster Only
Background/Objective - Methods - Results - Conclusion
Case Report – Poster Only
Introduction – Case Report - Discussion |
| Length | Title: Up to 30 words Body: Up to 300 words |
| Figure & Table | Only 1 figure & 1 table is allowed. * No more than 1 picture, table, graph, or figure should be included in a file. |
| Keywords | Up to three keywords |
| Funding Source (Optional) | If you have any funding source to disclose, please state it in ‘Funding Source’ section. |
Topic Categories
| 1 | Basic science and immunology related to rheumatic diseases | 10 | Osteoarthritis |
|---|---|---|---|
| 2 | Behcet's disease & Vasculitis | 11 | Osteoporosis and metabolic bone diseases |
| 3 | Crystal induced arthropathies | 12 | Pediatric rheumatology |
| 4 | Epidemiology & Public health | 13 | Rheumatoid Arthritis - Clinical Aspects |
| 5 | Fibromyalgia and soft tissue disorders | 14 | Rheumatoid Arthritis - Treatment |
| 6 | Idiopathic inflammatory myopathy | 15 | Sjögren's syndrome |
| 7 | Innovative medical research (Precision medicine, regenerative medicine, biotechnology, telemedicine, machine learning, artificial intelligence, etc.) | 16 | SLE-clinical aspects & treatment |
| 8 | Miscellaneous rheumatic and inflammatory diseases | 17 | Spondyloarthropathies and psoriatic arthritis |
| 9 | Orthopedics & Rehabilitation | 18 | Systemic sclerosis and Raynaud's phenomenon |
Abstract Review & Notification of Result
All submitted abstracts will be reviewed by the scientific committee according to the review process.
The topic category can be changed after the review of scientific committee. or submitted congress
Authors can submit abstracts for Oral and Poster. However, the final presentation type of the accepted abstract is under the discretion of Scientific Committee. (Case reports will be presented by poster only.)
The acceptance of abstracts will be notified by e-mail to the presenting author and corresponding author by no later than on February 26, 2024.
The presenting author whose abstract has been accepted needs to register with full payment for the congress to confirm their participation.
If the presenting author does not register by the registration deadline, the abstract will be automatically withdrawn from the final program.
If the presenter does do not attend the congress or present the abstract without any notification to the Secretariat of KCR 2024 in advance, there will be disadvantages in participating in the future meetings.
Withdrawal Policy
If you would like to withdraw an abstract, please fill out the “Withdrawal Request Form” and send it by e-mail to the KCR 2024 Secretariat.
If the presenter of the accepted abstract does not register by the deadline for Pre-Registration, the abstract will be automatically withdrawn from the final program.
If the presenter of the accepted abstract does not register by the deadline for Pre-Registration, the abstract will be automatically withdrawn from the final program.
Withdrawal Request Form
